ID   52M51
AC   CVCL_C3X1
DR   ABCD; ABCD_AF832
DR   Wikidata; Q116048264
RX   Patent=US8435513;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9405.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized brontictuzumab (OMP-52M51; 52M51H4L3) therapeutic antibody which was used in clinical trials for the treatment of lymphoid malignancies.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P46531; Human NOTCH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
RX   Patent=US8435513;
RA   Gurney A.L., Hoey T., Fitch-Bruhns M., Axelrod F.T.;
RT   "NOTCH1 receptor antibodies and methods of treatment.";
RL   Patent number US8435513, 07-May-2013.
//